Plasma Heparin-Like Activities After Percutaneous Application of a Low Molecular Weight Heparin in Healthy Subjects

Thromb Haemost 1986; 56(01): 109
DOI: 10.1055/s-0038-1661614

Letter to the Editor

Schattauer GmbH Stuttgart

Authors

B Rodemer

Department of Clinical Hemostaseology and Transfusion Medicine Medical School, University of Saarland, D-6650 Homburg/Saar, FRG
P Hellstern

Department of Clinical Hemostaseology and Transfusion Medicine Medical School, University of Saarland, D-6650 Homburg/Saar, FRG
E Wetzler

Department of Clinical Hemostaseology and Transfusion Medicine Medical School, University of Saarland, D-6650 Homburg/Saar, FRG
E Wenzel

Department of Clinical Hemostaseology and Transfusion Medicine Medical School, University of Saarland, D-6650 Homburg/Saar, FRG

References
1 Mehta PP, Sagar S, Kakkar VV. Treatment of superficial thrombophlebitis: A randomized, double-blind trial of heparinoid cream. Brit Med J 1975; 3: 614-616
2 Schäfer H, Zesch A. Die Penetration von Heparin in die menschliche Haut. Pharmazie 1976; 31: 251-254
3 Zesch A, Schäfer A. Penetration, Permeation und Resorption von Heparin. Drug Res 1976; 26: 1365-1368
4 Zimmermann RE. Untersuchungen zur transkutanen Heparinapplikation. Therapiewoche 1982; 32: 6157-6164
5 Bara L, Billaud E, Gramond G, Kher A, Samama M. Comparative pharmakokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration. Thromb Res 1985; 39: 631-638
6 Teien AN, Lie M. Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III. Thromb Res 1977; 10: 399-410